ICAM1 and asthma: We speculated that these bispecific antibody conjugates may also protect against RV infections because it has been shown that the administration of a human ICAM-1-specific antibody in a murine RV-asthma model inhibited the entry of RV into epithelial cells, and thus inhibited exacerbations of RV-induced lung inflammation [22].